Keyword: Elizabeth Warren

As the Trump administration works on its International Pricing Index proposal, pharma and conservative groups are on edge about a potential release.

A report from two senators concluded Eli Lilly's insulin generic has failed patients, but Lilly CEO David Ricks called that idea "nonsense."

In a letter sent to the FDA, five U.S. senators blasted Novartis for submitting—and failing to quickly disclose—manipulated Zolgensma data.

It didn't take long for critics to hit the ex-FDA chief's move to Pfizer. Elizabeth Warren, for one, said the job switch "smacks of corruption."

As the 2020 presidential election gets underway with the first Democratic debates, the pharma industry once again found itself an easy target.

The new Senate is once again sharpening its ax to cut pharma's DTC advertising tax deductions, a move now backed by a powerhouse group of Democrats.

Lawmakers on both sides of the aisle refuse to let go of the proposal to force drug pricing into consumer advertising, but they're not the only ones.

Drug prices took center stage at a contentious confirmation hearing for former Eli Lilly executive Alex Azar, who's up for the top job at HHS.

A California legislator is targeting pharma's use of copay coupons to promote pricey branded meds over cheaper alternatives.